Unlike proliferative activity, we observed, in CLL patients, a significant decrease in the IL-4+ BTLA-positive T cell compartment compared to the IL-4+ BTLA-negative T cell fraction (p = 0.008) (Table 2, Figure 3d). This evidence concerns the gene IL4 and B-cell chronic lymphocytic leukemia.